Doctor profile · Federal record
Dr. Nicole Wisowaty, PA-C
Physician Assistant · Schnecksville, PA
- NPI 1447898150
- Accepts Medicare
- MIPS 79.6 / 100 · 2023
- 7 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4110 Independence Dr Ste 300
Schnecksville, PA 180782584
(610) 769-4200
Credentials & registration
- NPI registered
- December 2019 — 7 yrs on file
- Profile last updated
- August 4, 2024
- Year of graduation
- 2019 — 7 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State license (1)
- Pennsylvania #MA061812
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1447898150. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
4,018
Distinct HCPCS
10
Medicare allowed
$199,977
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,234 | 270 | $5 | |
11102 |
Biopsy of related skin growth, first growth | 531 | 409 | $77 | |
17000 |
Destruction of precancer skin growth, 1 growth | 525 | 363 | $38 | |
11103 |
Biopsy of related skin growth, each additional growth | 457 | 232 | $41 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 381 | 278 | $73 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 336 | 224 | $104 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 205 | 205 | $92 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 119 | 119 | $135 | |
17110 |
Destruction of skin growth, 1-14 growths | 117 | 91 | $90 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 27 | 26 | $44 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 287. This provider delivers 14× the peer median.Open Payments
Industry payments received
All-time total
$2,224
Transactions
125
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 25 | $357.58 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $263.16 | |
| E.R. Squibb & Sons, L.L.C. | 22 | $262.80 | |
| UCB, Inc. | 14 | $222.30 | |
| LEO Pharma Inc. | 12 | $165.84 | |
| Dermavant Sciences, Inc. | 11 | $153.40 | |
| Janssen Biotech, Inc. | 3 | $116.66 | |
| Amgen Inc. | 5 | $112.38 | |
| Incyte Corporation | 5 | $102.64 | |
| PFIZER INC. | 4 | $73.34 | |
| Regeneron Healthcare Solutions, Inc. | 2 | $73.34 | |
| Lilly USA, LLC | 4 | $71.93 | |
| GENZYME CORPORATION | 2 | $61.06 | |
| Novartis Pharmaceuticals Corporation | 3 | $60.99 | |
| Galderma Laboratories, L.P. | 3 | $45.51 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
656
Patients
360
Total drug cost
$259,098
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 108 | 88 | $981 |
| Minoxidil | Generic | 99 | 17 | $337 |
| Clobetasol Propionate | Generic | 90 | 64 | $4,604 |
| Ketoconazole | Generic | 83 | 56 | $1,937 |
| Hydroxyzine Hcl | Generic | 38 | 14 | $236 |
| Minocycline Hcl | Generic | 30 | 28 | $646 |
| Mometasone Furoate | Generic | 29 | 13 | $742 |
| Ciclopirox (Ciclopirox Olamine) | Brand | 28 | 18 | $784 |
| Dupixent Pen (Dupilumab) | Brand | 27 | 0 | $113,773 |
| Otezla (Apremilast) | Brand | 26 | 0 | $129,918 |
Frequently asked questions
What is Dr. Nicole Wisowaty's medical specialty?
Dr. Nicole Wisowaty practices Physician Assistant in Schnecksville, PA.
Where does Dr. Nicole Wisowaty practice?
Dr. Nicole Wisowaty practices at 4110 Independence Dr Ste 300, Schnecksville, PA 180782584. Office phone: 6107694200.
What is Dr. Nicole Wisowaty's NPI?
Dr. Nicole Wisowaty's National Provider Identifier (NPI) is 1447898150, issued by NPPES.
Does Dr. Nicole Wisowaty accept Medicare assignment?
Yes. Dr. Nicole Wisowaty accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Nicole Wisowaty commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Biopsy of related skin growth, first growth (HCPCS 11102); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.